Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating activities:
Net income (loss)	$ 109,047	$ (10,376)
Reconciliation of net income (loss) to cash provided by (used in) operating activities:
Depreciation, amortization, and accretion	8,981	29,460
Gain on GP Sale	(120,574)	0
Impairment and other charges	0	5,371
Gain on retained CSI Compressco units and Standard Lithium shares	(3,992)	0
Equity-based compensation expense	2,478	784
Amortization of deferred financing costs	728	569
Insurance recoveries associated with damaged equipment	110	0
Debt-related expenses	93	0
Warrants fair value adjustment	323	(337)
Gain on sale of assets	(255)	(833)
Other non-cash charges	14	1,435
Changes in operating assets and liabilities, net of assets acquired:
Accounts receivable	1,501	3,601
Inventories	498	(12,414)
Prepaid expenses and other current assets	(1,060)	(2,442)
Trade accounts payable and accrued expenses	8,521	8,742
Other	(478)	(1,384)
Net cash provided by (used in) operating activities	5,825	22,176
Investing activities:
Purchases of property, plant, and equipment, net	6,761	12,390
Proceeds from sale of CCLP, net of cash divested	18	0
Proceeds on sale of property, plant, and equipment	561	1,425
Proceeds from Insurance Settlement, Investing Activities	110	0
Other investing activities	1,771	350
Net cash provided by (used in) investing activities	(4,301)	(10,615)
Financing activities:
Proceeds from long-term debt	160	56,512
Principal payments on long-term debt	(29,500)	(54,511)
CSI Compressco distributions	0	(309)
Tax remittances on equity based compensation	0	(319)
Repurchase of common stock	(449)	0
Debt issuance costs and other financing activities	(98)	(235)
Net cash provided by (used in) financing activities	(29,887)	1,138
Effect of exchange rate changes on cash	(1,303)	(940)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(29,666)	11,759
Cash and cash equivalents and restricted cash at beginning of period	83,894	17,768
Cash and cash equivalents at beginning of period associated with discontinued operations	16,577	2,370
Cash and cash equivalents and restricted cash at beginning of period associated with continuing operations	67,317	15,398
Cash and cash equivalents and restricted cash at end of period	54,228	29,527
Cash and cash equivalents at end of period associated with discontinued operations	0	7,416
Cash and cash equivalents and restricted cash at end of period associated with continuing operations	$ 54,228	$ 22,111